BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

13 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer.EBI
Hutchison Medipharma
Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors.EBI
Hutchison Medipharma
C-terminal SRC kinase inhibitorsBDB
Inventisbio Co.
Heterocyclic amide for inhibiting RIP1 kinase and uses thereofBDB
Shanghai Institute of Materia Medica
OXALAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITYBDB
Ifm Due
ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASEBDB
Biointervene
N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USEBDB
Pliant Therapeutics
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseaseBDB
Petra Pharma
Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenasesBDB
Beigene
Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoformBDB
Marquette University
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPRBDB
Pfizer
Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredientBDB
Korea Research Institute of Chemical Technology
Fused tricyclic dual inhibitors of CDK 4/6 and FLT3BDB
Amgen